Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

被引：0
|
作者：
Annemiek van Ommen-Nijhof
Judy N. Jacobse
Lars C. Steggink
Joop D. Lefrandt
Jourik A. Gietema
Flora E. van Leeuwen
Michael Schaapveld
Gabe S. Sonke
机构：
[1] The Netherlands Cancer Institute,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Radiotherapy
[3] Erasmus University Medical Center,Department of Medical Oncology
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University Medical Center Groningen,Department of Medical Oncology
[6] The Netherlands Cancer Institute,Department of Psychosocial Research and Epidemiology
[7] The Netherlands Cancer Institute,Department of Medical Oncology
[8] University of Amsterdam,Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2022年 / 196卷
关键词：
Breast cancer; Endocrine therapy; Aromatase inhibitor; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：591 / 602
页数：11
相关论文
共 50 条
  • [41] Aromatase inhibitors in adjuvant setting in breast cancer
    Spano, JP
    Khayat, D
    Delozier, T
    BULLETIN DU CANCER, 2004, 91 : S239 - S243
  • [42] Racial Differences in Depressive Symptoms and Self-Rated Health Among Breast Cancer Survivors on Aromatase Inhibitor Therapy
    Calhoun, Carla
    Helzlsouer, Kathy J.
    Gallicchio, Lisa
    JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 2015, 33 (03) : 263 - 277
  • [43] Aromatase inhibitors as adjuvant treatment of breast cancer
    Geisler, J
    Lonning, PE
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (01) : 53 - 61
  • [44] Treatment with aromatase inhibitors and markers of cardiovascular disease
    Blondeaux, Eva
    Musio, Debora
    Bruzzi, Paolo
    Lambertini, Matteo
    Gazzola, Valerio
    Poggio, Francesca
    Vecchio, Stefania
    Levaggi, Alessia
    D'Alonzo, Alessia
    Perfumo, Maria Cecilia
    Bighin, Claudia
    Giraudi, Sara
    Palombo, Domenico
    Del Mastro, Lucia
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 261 - 267
  • [45] Evolution of endocrine adjuvant therapy for early breast cancer
    Lonning, Per Eystein
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 : S19 - S30
  • [46] Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy
    Otte, Julie L.
    Flockhart, David
    Hayes, Daniel
    Storniolo, Anna Maria
    Stearns, Vered
    Schneider, Bryan
    Henry, N. Lynn
    Azzouz, Faouzi
    Nguyen, Anne
    Lemler, Suzanne
    Hayden, Jill
    Jeter, Stacie
    Wright, Laurie
    Carpenter, Janet S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (04): : 653 - 659
  • [47] Impact of Yoga on Functional Outcomes in Breast Cancer Survivors With Aromatase Inhibitor-Associated Arthralgias
    Galantino, Mary Lou
    Desai, Krupali
    Greene, Laurie
    DeMichele, Angela
    Stricker, Carrie Tompkins
    Mao, Jun James
    INTEGRATIVE CANCER THERAPIES, 2012, 11 (04) : 313 - 320
  • [48] Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer
    Chlebowski, Rowan
    Cuzick, Jack
    Amakye, Dereck
    Bauerfeind, Ingo
    Buzdar, Aman
    Chia, Stephen
    Cutuli, Bruno
    Linforth, Rick
    Maass, Nicolai
    Noguchi, Shinzaburo
    Robidoux, Andre
    Verma, Sunil
    Hadji, Peyman
    BREAST, 2009, 18 : S1 - S11
  • [49] High risk for cardiovascular disease in postmenopausal breast cancer survivors
    Brito Buttros, Daniel de Araujo
    Branco, Mauro Terra
    Orsatti, Claudio Lera
    Almeida-Filho, Benedito de Sousa
    Nahas-Neto, Jorge
    Nahas, Eliana A. P.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (09): : 1024 - 1030
  • [50] Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies
    Dixon, J. Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (18) : 2465 - 2479
12345